Product Information
CONCEPT DHA CAPSULE is a brand product labeled by U.S. Pharmaceutical Corporation, priced at $1.1610 per EA under NDC 52747062130. Its NADAC has been published 404 times since Nov 28, 2013.
Strength
25; 300; 5; 2; 12.5; 17.5; 1; 17.5; 5; 1.8; 200; 25; 3; 2; 10 mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1
Manufacturer
U.S. Pharmaceutical CorporationNDC
52747062130
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
10/1/2026
Approval Type
Unapproved
On Market Since
6/24/2009
Pharmacological Classes
Price Statistics
The NADAC for CONCEPT DHA CAPSULE has been published 404 times since Nov 28, 2013, and over the history we have for it it has risen 28.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1610 per EA |
|---|---|
| All-time high | $1.1610 (Sep 30, 2026) |
| All-time low | $0.9051 (Sep 17, 2014) |
| 52-week high | $1.1610 |
| 52-week low | $1.0548 |
| Median price | $0.9752 |
| Average price | $0.9746 |
| Largest weekly change | +10.0% (Sep 30, 2026) |
| Weeks tracked | 404 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Vitamin- Mineral Omega-3 Supplement market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Weekly brief
Featured in the latest weekly brief
This NDC appears in the current executive summary of the most important weekly NADAC moves.
Manufacturer
U.S. Pharmaceutical Corporation manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vitamin- Mineral Omega-3 Supplement market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calculi Dissolution Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CONCEPT DHA CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CONCEPT DHA CAPSULE, manufactured by U.S. Pharmaceutical Corporation, is $1.1610 per EA (NDC 52747062130), effective Sep 30, 2026.
How has the price of CONCEPT DHA CAPSULE changed over time?
Over the history we have for it, the NADAC for CONCEPT DHA CAPSULE has risen 28.0%. It has been tracked across 404 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CONCEPT DHA CAPSULE?
Since Nov 28, 2013, the NADAC for CONCEPT DHA CAPSULE has ranged from a low of $0.9051 (Sep 17, 2014) to a high of $1.1610 (Sep 30, 2026), with a median of $0.9752 per EA.
Are there cheaper alternatives to CONCEPT DHA CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CONCEPT DHA CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CONCEPT DHA CAPSULE?
CONCEPT DHA CAPSULE (NDC 52747062130) is labeled by U.S. Pharmaceutical Corporation, and CMS classifies it as a brand product.